Overview

NovoLetĀ® Acceptance Study Within the Hospital Practise in Indonesia

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this study is to evaluate the overall acceptance of healthcare professionals (nurses and doctors) to the NovoLetĀ® system used in a hospital environment.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc